MedTrace Logo

Efficacy of Oral Corticosteroid Therapy in Recurrent Paralyzes After Thyroidectomy

NCT03553342 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2021-01-29

No results posted yet for this study

Summary

Thyroidectomy is a common surgical procedure in France. Recurrent paralysis is one of the main complications. Oral corticosteroid therapy are frequently used at a dosage of 1mg/kg for seven days, in case of recurrent paralysis to obtain remobilization as early as possible.

The main objective is to evaluate the efficacy of oral corticosteroid therapy in remobilization of vocal cords at seven days in patients with unilateral recurrent paralysis after thyroidectomy.

Conditions

  • Recurrent Paralysis of Vocal Cords

Interventions

DRUG

Corticoids

Patients will receive corticosteroids therapy: 1mg/kg of prednisolone daily for seven days.

OTHER

Placebo

Patients will receive placebo for seven days.

Sponsors & Collaborators

  • Poitiers University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-11
Primary Completion
2021-09-11
Completion
2022-01-11

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03553342 on ClinicalTrials.gov